...
首页> 外文期刊>Renal failure. >Kidney transplantation outcomes from expanded criteria donors, standard criteria donors or living donors older than 60 years
【24h】

Kidney transplantation outcomes from expanded criteria donors, standard criteria donors or living donors older than 60 years

机译:来自扩展标准供体,标准供体或年龄超过60岁的活体供体的肾脏移植结果

获取原文
           

摘要

Objectives: To evaluate outcomes in kidney allograft recipients from donors with expanded criteria (ECD) versus standard criteria (SCD) or living donors (LD) >60 years. Methods: We studied all patients who received a kidney between 2005 and 2011, focusing in recipients of kidneys from deceased ECD, SCD and LD >60 years. ECD was any deceased donor >60 years or >50 years with two of the following: hypertension (HTN), stroke as the cause of death, or serum creatinine >1.5?mg/dL. We recorded characteristics of the transplant procedure, patient, graft survival and renal function 1 year after transplantation and at the end of follow-up. Results: Six-hundred and five patients were transplanted between 2005 and 2011 in our department. There were 142 (25.1%) transplantations from ECD, 192 (33.98%) from SCD and 96 (16.99%) from LDs older than 60 years. In a mean follow-up time of 36.4 months, graft survival rates were similar for all groups. Calculated GFR was found statistically different between the ECD and SCD groups, but still satisfactory at first year, and at end of follow-up time. Comparison of the patients, who received transplants from ECD, even older than 70 years, and those from LD >60 years revealed equivalent renal function in short and long term. Conclusions: Utilization of marginal kidneys effectively doubled our deceased transplant volume in the period 2005–2011. Patients’ and graft survival were shown similar at the end of follow-up for all groups. Renal outcomes were shown equivalent between the ECD and LD >60 years groups, and although significantly lower between the ECD and the SCD group, were still very satisfactory.
机译:目的:评估来自扩展标准(ECD)与标准标准(SCD)或活体供体(LD)> 60年的供体的肾脏同种异体移植受体的结果。方法:我们研究了2005年至2011年期间接受肾脏治疗的所有患者,重点是已故ECD,SCD和LD> 60岁的肾脏接受者。 ECD是任何> 60岁或> 50岁的已故捐赠者,其中有以下两项:高血压(HTN),中风为死亡原因或血清肌酐> 1.5?mg / dL。我们记录了移植后1年和随访结束时的移植程序,患者,移植物存活率和肾功能的特征。结果:2005年至2011年间,本科共移植了650例患者。来自ECD的移植142例(25.1%),来自SCD的192例(33.98%)和60岁以上的LD的96例(16.99%)。平均随访时间为36.4个月,所有组的移植物存活率均相似。发现ECD和SCD组之间的GFR计算存在统计学差异,但在第一年和随访期末仍令人满意。比较接受ECD甚至超过70岁的患者和LD> 60岁的患者的短期和长期肾功能相同。结论:在2005年至2011年期间,利用边缘肾有效地使我们已故的移植量​​增加了一倍。随访结束时,所有组的患者和移植物存活率均相似。在ECD和LD> 60岁组之间,肾脏结局显示相当,尽管ECD和SCD组之间的肾结局明显降低,但仍然非常令人满意。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号